고초열성 결막염(계절성 알레르기성 결막염) : 시장 인사이트, 역학 및 시장 예측(-2034년)

Hay Fever Conjunctivitis - Market Insight, Epidemiology, and Market Forecast - 2034

US $ 7,950 ￦ 11,556,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,925 ￦ 17,335,000

PDF (2-3 User License)

PDF 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 15,900 ￦ 23,113,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 23,850 ￦ 34,670,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

앞으로 몇 년동안 고초열성 결막염(계절성 알레르기성 결막염) 시장은 이 질환에 대한 인식이 높아지고 전 세계 의료비 지출이 증가함에 따라 변화할 것으로 예상됩니다.

기업과 연구기관들은 고초열성 결막염(계절성 알레르기성 결막염) 연구 개발에 영향을 미칠 수 있는 과제를 평가하고 기회를 모색하기 위해 노력하고 있습니다. 개발 중인 치료법은 질환을 치료/개선하기 위한 새로운 접근법에 초점을 맞추었습니다. 주요 기업들이 고초열성 결막염(계절성 알레르기성 결막염) 치료제 개발에 참여하고 있습니다. 새로운 치료법의 등장은 고초열성 결막염(계절성 알레르기 결막염) 시장에 큰 영향을 미칠 것으로 예상됩니다.

이 보고서는 주요 7개국의 고초열성 결막염(계절성 알레르기성 결막염) 시장을 조사했으며, 시장 개요와 함께 역학, 환자 동향, 새로운 치료법, 2034년까지 시장 규모 예측, 미충족 의료 수요 등의 정보를 제공합니다.

목차

제1장 중요 인사이트

제2장 고초열성 결막염(계절성 알레르기성 결막염)에 대한 요약

제3장 고초열성 결막염(계절성 알레르기성 결막염) 경쟁 정보 분석

제4장 고초열성 결막염(계절성 알레르기성 결막염) : 시장 개요

제5장 고초열성 결막염(계절성 알레르기성 결막염) : 질환의 배경과 개요

• 서론
• 징후와 증상
• 병태생리학
• 위험 요인
• 진단

제6장 환자 동향

제7장 고초열성 결막염(계절성 알레르기성 결막염)의 역학과 환자군

• 역학 주요 조사 결과
• 전제 및 근거 : 주요 7개 국가
• 역학 시나리오 : 주요 7개 국가
• 미국
• 유럽 5개국
• 일본 역학

제8장 치료 알고리즘, 현재의 치료법 및 의료행위

제9장 미충족 욕구

제10장 고초열성 결막염(계절성 알레르기성 결막염) 치료의 주요 평가 항목

제11장 시판 제품

제12장 새로운 치료법

제13장 고초열성 결막염(계절성 알레르기성 결막염) : 주요 7개국 시장 분석

제14장 속성 분석

제15장 주요 7개국 : 시장 전망

• 미국 : 시장 규모
• 유럽 5개국 : 시장 규모 및 전망
• 독일 시장 규모
• 프랑스 시장 규모
• 이탈리아 시장 규모
• 스페인 시장 규모
• 영국 시장 규모
• 일본 시장 규모

제16장 고초열성 결막염(계절성 알레르기성 결막염) 접근성 및 보험급여 개요

제17장 KOL의 견해

제18장 시장 성장 촉진요인

제19장 시장의 장벽

제20장 부록

제21장 DelveInsight의 서비스 내용

제22장 면책사항

제23장 DelveInsight에 대해

LSH

영문 목차

영문목차

DelveInsight's "Hay Fever Conjunctivitis - Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hay Fever Conjunctivitis, historical and forecasted epidemiology as well as the Hay Fever Conjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Hay Fever Conjunctivitis market report provides current treatment practices, emerging drugs, Hay Fever Conjunctivitis market share of the individual therapies, current and forecasted Hay Fever Conjunctivitis market size from 2020 to 2034 segmented by seven major markets. The Report also covers current Hay Fever Conjunctivitis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Geography Covered:

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2020-2034

Hay Fever Conjunctivitis Disease Understanding and Treatment Algorithm

The DelveInsight Hay Fever Conjunctivitis market report gives a thorough understanding of the Hay Fever Conjunctivitis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.

Diagnosis

This segment of the report covers the detailed diagnostic methods or tests for Hay Fever Conjunctivitis.

Treatment

It covers the details of conventional and current medical therapies available in the Hay Fever Conjunctivitis market for the treatment of the condition. It also provides Hay Fever Conjunctivitis treatment algorithms and guidelines in the United States, Europe, and Japan.

Hay Fever Conjunctivitis Epidemiology

The Hay Fever Conjunctivitis epidemiology division provide insights about historical and current Hay Fever Conjunctivitis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Hay Fever Conjunctivitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034.

Country Wise-Hay Fever Conjunctivitis Epidemiology

The epidemiology segment also provides the Hay Fever Conjunctivitis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Hay Fever Conjunctivitis Drug Chapters

Drug chapter segment of the Hay Fever Conjunctivitis report encloses the detailed analysis of Hay Fever Conjunctivitis marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Hay Fever Conjunctivitis clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Marketed Drugs

The report provides the details of the marketed product available for Hay Fever Conjunctivitis treatment.

Hay Fever Conjunctivitis Emerging Drugs

The report provides the details of the emerging therapies under the late and mid-stage of development for Hay Fever Conjunctivitis treatment.

Hay Fever Conjunctivitis Market Outlook

The Hay Fever Conjunctivitis market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hay Fever Conjunctivitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.

This segment gives a thorough detail of Hay Fever Conjunctivitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, Hay Fever Conjunctivitis market in 7MM is expected to change in the study period 2020-2034.

Key Findings

This section includes a glimpse of the Hay Fever Conjunctivitis market in 7MM.

The United States Market Outlook

This section provides the total Hay Fever Conjunctivitis market size and market size by therapies in the United States.

EU-5 Countries: Market Outlook

The total Hay Fever Conjunctivitis market size and market size by therapies in Germany, France, Italy, Spain, and the United Kingdom is provided in this section.

Japan Market Outlook

The total Hay Fever Conjunctivitis market size and market size by therapies in Japan is also mentioned.

Hay Fever Conjunctivitis Drugs Uptake

This section focusses on the rate of uptake of the potential drugs recently launched in the Hay Fever Conjunctivitis market or expected to get launched in the market during the study period 2020-2034. The analysis covers Hay Fever Conjunctivitis market uptake by drugs; patient uptake by therapies; and sales of each drug.

This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Hay Fever Conjunctivitis Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stage. It also analyses Hay Fever Conjunctivitis key players involved in developing targeted therapeutics.

Pipeline Development Activities

The report covers the detailed information of collaborations, acquisition and merger, licensing, patent details and other information for Hay Fever Conjunctivitis emerging therapies.

Reimbursement Scenario in Hay Fever Conjunctivitis

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we take reimbursement into consideration to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

KOL- Views

To keep up with current market trends, we take KOLs and SME's opinion working in Hay Fever Conjunctivitis domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Hay Fever Conjunctivitis market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.

Competitive Intelligence Analysis

We perform Competitive and Market Intelligence analysis of the Hay Fever Conjunctivitis Market by using various Competitive Intelligence tools that include - SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.

Scope of the Report:

• The report covers the descriptive overview of Hay Fever Conjunctivitis, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Hay Fever Conjunctivitis epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Hay Fever Conjunctivitis are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Hay Fever Conjunctivitis market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hay Fever Conjunctivitis market

Report Highlights:

• In the coming years, Hay Fever Conjunctivitis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Hay Fever Conjunctivitis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Hay Fever Conjunctivitis. Launch of emerging therapies will significantly impact the Hay Fever Conjunctivitis market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Hay Fever Conjunctivitis
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

Hay Fever Conjunctivitis Report Insights

• Patient Population
• Therapeutic Approaches
• Hay Fever Conjunctivitis Pipeline Analysis
• Hay Fever Conjunctivitis Market Size and Trends
• Market Opportunities
• Impact of upcoming Therapies

Hay Fever Conjunctivitis Report Key Strengths

• 11 Years Forecast
• 7MM Coverage
• Hay Fever Conjunctivitis Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake

Hay Fever Conjunctivitis Report Assessment

• Current Treatment Practices
• Unmet Needs
• Pipeline Product Profiles
• Market Attractiveness
• Market Drivers and Barriers

Key Questions:

Market Insights:

• What was the Hay Fever Conjunctivitis market share (%) distribution in 2020 and how it would look like in 2034?
• What would be the Hay Fever Conjunctivitis total market size as well as market size by therapies across the 7MM during the forecast period (2024-2034)?
• What are the key findings pertaining to the market across 7MM and which country will have the largest Hay Fever Conjunctivitis market size during the forecast period (2024-2034)?
• At what CAGR, the Hay Fever Conjunctivitis market is expected to grow in 7MM during the forecast period (2020-2034)?
• What would be the Hay Fever Conjunctivitis market outlook across the 7MM during the forecast period (2020-2034)?
• What would be the Hay Fever Conjunctivitis market growth till 2032, and what will be the resultant market Size in the year 2034?
• How would the market drivers, barriers and future opportunities affect the market dynamics and subsequent analysis of the associated trends?

Epidemiology Insights:

• What is the disease risk, burden and unmet needs of the Hay Fever Conjunctivitis?
• What is the historical Hay Fever Conjunctivitis patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What would be the forecasted patient pool of Hay Fever Conjunctivitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hay Fever Conjunctivitis?
• Out of all 7MM countries, which country would have the highest prevalent population of Hay Fever Conjunctivitis during the forecast period (2020-2034)?
• At what CAGR the population is expected to grow in 7MM during the forecast period (2020-2034)?

Current Treatment Scenario, Marketed Drugs and Emerging Therapies:

• What are the current options for the Hay Fever Conjunctivitis treatment, along with the approved therapy?
• What are the current treatment guidelines for the treatment of Hay Fever Conjunctivitis in the USA, Europe, and Japan?
• What are the Hay Fever Conjunctivitis marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Hay Fever Conjunctivitis?
• How many therapies are developed by each company for Hay Fever Conjunctivitis treatment?
• How many are emerging therapies in mid-stage, and late stage of development for Hay Fever Conjunctivitis treatment?
• What are the key collaborations (Industry - Industry, Industry - Academia), Mergers and acquisitions, licensing activities related to the Hay Fever Conjunctivitis therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Hay Fever Conjunctivitis and their status?
• What are the key designations that have been granted for the emerging therapies for Hay Fever Conjunctivitis?
• What are the global historical and forecasted market of Hay Fever Conjunctivitis?

Reasons to buy:

• The report will help in developing business strategies by understanding trends shaping and driving the Hay Fever Conjunctivitis market
• To understand the future market competition in the Hay Fever Conjunctivitis market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Hay Fever Conjunctivitis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Hay Fever Conjunctivitis market
• To understand the future market competition in the Hay Fever Conjunctivitis market

Table of Contents

1. Key Insights

2. Executive Summary of Hay Fever Conjunctivitis

3. Competitive Intelligence Analysis for Hay Fever Conjunctivitis

4. Hay Fever Conjunctivitis: Market Overview at a Glance

• 4.1. Hay Fever Conjunctivitis Total Market Share (%) Distribution in 2020
• 4.2. Hay Fever Conjunctivitis Total Market Share (%) Distribution in 2034

5. Hay Fever Conjunctivitis: Disease Background and Overview

• 5.1. Introduction
• 5.2. Sign and Symptoms
• 5.3. Pathophysiology
• 5.4. Risk Factors
• 5.5. Diagnosis

6. Patient Journey

7. Hay Fever Conjunctivitis Epidemiology and Patient Population

• 7.1. Epidemiology Key Findings
• 7.2. Assumptions and Rationale: 7MM
• 7.3. Epidemiology Scenario: 7MM
  • 7.3.1. Hay Fever Conjunctivitis Epidemiology Scenario in the 7MM (2020-2034)
• 7.4. United States Epidemiology
  • 7.4.1. Hay Fever Conjunctivitis Epidemiology Scenario in the United States (2020-2034)
• 7.5. EU-5 Country-wise Epidemiology
  • 7.5.1. Germany Epidemiology
    • 7.5.1.1. Hay Fever Conjunctivitis Epidemiology Scenario in Germany (2020-2034)
  • 7.5.2. France Epidemiology
    • 7.5.2.1. Hay Fever Conjunctivitis Epidemiology Scenario in France (2020-2034)
  • 7.5.3. Italy Epidemiology
    • 7.5.3.1. Hay Fever Conjunctivitis Epidemiology Scenario in Italy (2020-2034)
  • 7.5.4. Spain Epidemiology
    • 7.5.4.1. Hay Fever Conjunctivitis Epidemiology Scenario in Spain (2020-2034)
  • 7.5.5. United Kingdom Epidemiology
    • 7.5.5.1. Hay Fever Conjunctivitis Epidemiology Scenario in the United Kingdom (2020-2034)
  • 7.5.6. Japan Epidemiology
    • 7.5.6.1. Hay Fever Conjunctivitis Epidemiology Scenario in Japan (2020-2034)

8. Treatment Algorithm, Current Treatment, and Medical Practices

• 8.1. Hay Fever Conjunctivitis Treatment and Management
• 8.2. Hay Fever Conjunctivitis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Hay Fever Conjunctivitis Treatment

11. Marketed Products

• 11.1. List of Marketed Products in the 7MM
• 11.2. Drug Name: Company Name
  • 11.2.1. Product Description
  • 11.2.2. Regulatory Milestones
  • 11.2.3. Other Developmental Activities
  • 11.2.4. Pivotal Clinical Trials
  • 11.2.5. Summary of Pivotal Clinical Trial

List to be continued in report

12. Emerging Therapies

• 12.1. Key Cross
• 12.2. Drug Name: Company Name
  • 12.2.1. Product Description
  • 12.2.2. Other Developmental Activities
  • 12.2.3. Clinical Development
  • 12.2.4. Safety and Efficacy
  • 12.2.5. Product Profile

List to be continued in report

13. Hay Fever Conjunctivitis: Seven Major Market Analysis

• 13.1. Key Findings
• 13.2. Hay Fever Conjunctivitis Market Size in 7MM
• 13.3. Hay Fever Conjunctivitis Market Size by Therapies in the 7MM

14. Attribute analysis

15. 7MM: Market Outlook

• 15.1. United States: Market Size
  • 15.1.1. Hay Fever Conjunctivitis Total Market Size in the United States
  • 15.1.2. Hay Fever Conjunctivitis Market Size by Therapies in the United States
• 15.2. EU-5 countries: Market Size and Outlook
• 15.3. Germany Market Size
  • 15.3.1. Hay Fever Conjunctivitis Total Market Size in Germany
  • 15.3.2. Hay Fever Conjunctivitis Market Size by Therapies in Germany
• 15.4. France Market Size
  • 15.4.1. Hay Fever Conjunctivitis Total Market Size in France
  • 15.4.2. Hay Fever Conjunctivitis Market Size by Therapies in France
• 15.5. Italy Market Size
  • 15.5.1. Hay Fever Conjunctivitis Total Market Size in Italy
  • 15.5.2. Hay Fever Conjunctivitis Market Size by Therapies in Italy
• 15.6. Spain Market Size
  • 15.6.1. Hay Fever Conjunctivitis Total Market Size in Spain
  • 15.6.2. Hay Fever Conjunctivitis Market Size by Therapies in Spain
• 15.7. United Kingdom Market Size
  • 15.7.1. Hay Fever Conjunctivitis Total Market Size in the United Kingdom
  • 15.7.2. Hay Fever Conjunctivitis Market Size by Therapies in the United Kingdom
• 15.8. Japan Market Outlook
  • 15.8.1. Japan Market Size
  • 15.8.2. Hay Fever Conjunctivitis Total Market Size in Japan
  • 15.8.3. Hay Fever Conjunctivitis Market Size by Therapies in Japan

16. Access and Reimbursement Overview of Hay Fever Conjunctivitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

• 20.1. Bibliography
• 20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

The table of contents is not exhaustive; the final content may vary.

관련자료